0001660549-16-000003.txt : 20160420 0001660549-16-000003.hdr.sgml : 20160420 20160420120158 ACCESSION NUMBER: 0001660549-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160420 DATE AS OF CHANGE: 20160420 EFFECTIVENESS DATE: 20160420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advantagene, Inc. CENTRAL INDEX KEY: 0001660549 IRS NUMBER: 522214857 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-261703 FILM NUMBER: 161580763 BUSINESS ADDRESS: STREET 1: 440 LEXINGTON STREET CITY: AUBURNDALE STATE: MA ZIP: 02466 BUSINESS PHONE: 617-916-5445 MAIL ADDRESS: STREET 1: 440 LEXINGTON STREET CITY: AUBURNDALE STATE: MA ZIP: 02466 D 1 primary_doc.xml X0707 D LIVE 0001660549 Advantagene, Inc. 440 LEXINGTON STREET AUBURNDALE MA MASSACHUSETTS 02466 617-916-5445 DELAWARE None None Corporation true Estuardo Aguilar-Cordova c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Executive Officer Director Laura Aguilar c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Executive Officer Stephen C. Rocamboli c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Executive Officer Mitchell Finer c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Director Udi Merav c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Director Fred Mermelstein c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Director Glenn Mattes c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Director Alan Smith c/o 440 Lexington Street Auburndale MA MASSACHUSETTS 02466 Director Biotechnology Decline to Disclose 06b false 2016-04-05 false true false 0 National Securities Corporation 7569 National Securities Corporation 7569 410 Park Avenue, 14th Floor New York NY NEW YORK 10022 All States false 35000000 5023929 29976071 false 108 512392 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Advantagene, Inc. /s/ Stephen C. Rocamboli Stephen C. Rocamboli Chief Business Officer 2016-04-19